Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 134,397 | 130,577 | 129,637 | 128,210 | 125,343 |
| Cost of Goods | 106,805 | 102,930 | 104,588 | 101,517 | 96,617 |
| Gross Profit | 27,592 | 27,647 | 25,049 | 26,693 | 28,726 |
| Operating Expenses | 8,594 | 12,569 | 17,066 | 12,629 | 14,671 |
| Operating Income | 19,803 | 16,008 | 8,571 | 14,581 | 14,672 |
| Interest Expense | 3,108 | 3,209 | 3,423 | 3,618 | 3,147 |
| Pre-tax Income | 16,695 | 12,799 | 5,148 | 10,963 | 11,525 |
| Income Tax | 4,691 | 3,609 | 1,658 | 8,529 | 2,305 |
| Net Income Continuous | 12,004 | 9,190 | 3,490 | 2,434 | 9,220 |
| Minority Interests | 259 | 158 | 270 | 235 | -37 |
| Net Income | $11,745 | $9,032 | $3,220 | $2,199 | $9,257 |
| EPS Basic Total Ops | 0.25 | 0.19 | 0.07 | 0.05 | 0.20 |
| EPS Basic Continuous Ops | 0.26 | 0.20 | 0.07 | 0.05 | 0.20 |
| EPS Diluted Total Ops | 0.25 | 0.19 | 0.07 | 0.05 | 0.19 |
| EPS Diluted Continuous Ops | 0.25 | 0.19 | 0.07 | 0.05 | 0.19 |
| EPS Diluted Before Non-Recurring Items | 0.27 | 0.22 | 0.13 | N/A | N/A |
| EBITDA(a) | $23,479 | $19,778 | $12,414 | $18,455 | $18,601 |